Sea Lane Biotechnologies Release: Scientists Create First Successful Libraries of Avian Flu Virus Antibodies
4/15/2008 10:04:17 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--An international group of American and Turkish research scientists, led by Sea Lane Biotechnologies, has created the first comprehensive monoclonal antibody libraries against avian influenza (H5N1) using samples from survivors of the 2005/2006 "bird flu" outbreak in Turkey. These antibody libraries hold the promise for developing a therapy that could stop a pandemic in its tracks and provide treatment to those infected, as well as potentially pointing the way towards the development of a universal flu vaccine. The expanded treatment and containment options offered by Sea Lane’s antibody libraries could help provide healthcare officials, researchers, and governments with unprecedented resources to combat this serious global health threat.
comments powered by